| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 917 | 2020 |
| Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ... Journal of the American College of Cardiology 75 (21), 2649-2660, 2020 | 303 | 2020 |
| Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II O Wever-Pinzon, CH Selzman, SG Drakos, A Saidi, GJ Stoddard, ... Circulation: Heart Failure 6 (3), 517-526, 2013 | 246 | 2013 |
| Meta-analysis of randomized trials of angioedema as an adverse event of renin–angiotensin system inhibitors H Makani, FH Messerli, J Romero, O Wever-Pinzon, A Korniyenko, ... The American journal of cardiology 110 (3), 383-391, 2012 | 212 | 2012 |
| Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery SG Drakos, O Wever-Pinzon, CH Selzman, EM Gilbert, R Alharethi, ... Journal of the American College of Cardiology 61 (19), 1985-1994, 2013 | 198* | 2013 |
| Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema H Makani, S Bangalore, J Romero, O Wever-Pinzon, FH Messerli The American journal of medicine 124 (2), 128-135, 2011 | 186 | 2011 |
| Cardiac recovery during long-term left ventricular assist device support O Wever-Pinzon, SG Drakos, SH McKellar, BD Horne, WT Caine, ... Journal of the American College of Cardiology 68 (14), 1540-1553, 2016 | 180 | 2016 |
| Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept I Taleb, AG Koliopoulou, A Tandar, SH McKellar, JE Tonna, ... Circulation 140 (1), 98-100, 2019 | 174 | 2019 |
| Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic … O Wever-Pinzon, SG Drakos, AG Kfoury, JN Nativi, EM Gilbert, M Everitt, ... Circulation 127 (4), 452-462, 2013 | 169 | 2013 |
| Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials O Wever-Pinzon, J Romero, I Kelesidis, J Wever-Pinzon, C Manrique, ... Journal of the American College of Cardiology 63 (19), 1992-2004, 2014 | 156 | 2014 |
| Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial DL Mann, MM Givertz, JM Vader, RC Starling, P Shah, SE McNulty, ... JAMA cardiology 7 (1), 17-25, 2022 | 146 | 2022 |
| Twelfth interagency registry for mechanically assisted circulatory support report: readmissions after left ventricular assist device P Shah, M Yuzefpolskaya, GW Hickey, K Breathett, O Wever-Pinzon, ... The Annals of thoracic surgery 113 (3), 722-737, 2022 | 132 | 2022 |
| Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices MY Yin, O Wever-Pinzon, MR Mehra, CH Selzman, AE Toll, WS Cherikh, ... The Journal of Heart and Lung Transplantation 38 (8), 858-869, 2019 | 102 | 2019 |
| Association of recipient age and causes of heart transplant mortality: implications for personalization of post-transplant management—an analysis of the International Society … O Wever-Pinzon, LB Edwards, DO Taylor, AG Kfoury, SG Drakos, ... The Journal of Heart and Lung Transplantation 36 (4), 407-417, 2017 | 90 | 2017 |
| Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device–induced myocardial recovery NA Diakos, CH Selzman, FB Sachse, J Stehlik, AG Kfoury, ... Journal of the American College of Cardiology 64 (15), 1602-1612, 2014 | 83 | 2014 |
| Vigorous exercise in patients with hypertrophic cardiomyopathy R Lampert, MJ Ackerman, BS Marino, M Burg, B Ainsworth, L Salberg, ... JAMA cardiology 8 (6), 595-605, 2023 | 78 | 2023 |
| Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes BA Maron, RS Wang, S Shevtsov, SG Drakos, E Arons, O Wever-Pinzon, ... Nature communications 12 (1), 873, 2021 | 74 | 2021 |
| Reflections of inflections in hypertrophic cardiomyopathy MV Sherrid, O Wever-Pinzon, A Shah, FA Chaudhry Journal of the American College of Cardiology 54 (3), 212-219, 2009 | 74 | 2009 |
| DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure ME Pepin, S Drakos, CM Ha, M Tristani-Firouzi, CH Selzman, JC Fang, ... American Journal of Physiology-Heart and Circulatory Physiology, 2019 | 71 | 2019 |
| The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure R Badolia, DKA Ramadurai, ED Abel, P Ferrin, I Taleb, TS Shankar, ... Circulation 142 (3), 259-274, 2020 | 66 | 2020 |
Stavros G. DrakosΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα hsc.utah.edu
